S.F. Josephs

1.0k total citations
14 papers, 615 citations indexed

About

S.F. Josephs is a scholar working on Virology, Epidemiology and Molecular Biology. According to data from OpenAlex, S.F. Josephs has authored 14 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Virology, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in S.F. Josephs's work include HIV Research and Treatment (8 papers), Cytomegalovirus and herpesvirus research (5 papers) and Viral-associated cancers and disorders (4 papers). S.F. Josephs is often cited by papers focused on HIV Research and Treatment (8 papers), Cytomegalovirus and herpesvirus research (5 papers) and Viral-associated cancers and disorders (4 papers). S.F. Josephs collaborates with scholars based in United States, Germany and Netherlands. S.F. Josephs's co-authors include N Balachandran, S. Zaki Salahuddin, Dharam V. Ablashi, Robert C. Gallo, B. Kramarsky, Chia‐Yen Hung, Flavia Borellini, A. Aquino, Robert I. Glazer and Flossie Wong‐Staal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

S.F. Josephs

14 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.F. Josephs United States 9 402 244 175 130 111 14 615
Christine Kaschka‐Dierich Germany 8 372 0.9× 465 1.9× 183 1.0× 71 0.5× 23 0.2× 11 651
Marlene Chernow United States 8 252 0.6× 58 0.2× 102 0.6× 71 0.5× 128 1.2× 9 445
Anita Koroknai Hungary 14 103 0.3× 226 0.9× 138 0.8× 114 0.9× 41 0.4× 25 435
Lisa R. Bishop United States 11 201 0.5× 66 0.3× 134 0.8× 64 0.5× 25 0.2× 17 376
J. R. Arrand United Kingdom 11 239 0.6× 290 1.2× 87 0.5× 25 0.2× 37 0.3× 12 388
Lidia M. Martos United States 11 227 0.6× 271 1.1× 152 0.9× 73 0.6× 18 0.2× 15 433
Heather Dyson United Kingdom 7 400 1.0× 325 1.3× 143 0.8× 45 0.3× 25 0.2× 8 602
Helena Costa Sweden 11 221 0.5× 86 0.4× 35 0.2× 77 0.6× 40 0.4× 16 358
Shara N. Pantry United States 6 179 0.4× 125 0.5× 77 0.4× 80 0.6× 60 0.5× 6 330
Jeanette Erbo Christensen Denmark 13 126 0.3× 136 0.6× 87 0.5× 61 0.5× 53 0.5× 13 631

Countries citing papers authored by S.F. Josephs

Since Specialization
Citations

This map shows the geographic impact of S.F. Josephs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.F. Josephs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.F. Josephs more than expected).

Fields of papers citing papers by S.F. Josephs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.F. Josephs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.F. Josephs. The network helps show where S.F. Josephs may publish in the future.

Co-authorship network of co-authors of S.F. Josephs

This figure shows the co-authorship network connecting the top 25 collaborators of S.F. Josephs. A scholar is included among the top collaborators of S.F. Josephs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.F. Josephs. S.F. Josephs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Josephs, S.F., et al.. (1999). In vivo delivery of recombinant human growth hormone from genetically engineered human fibroblasts implanted within Baxter immunoisolation devices. Journal of Molecular Medicine. 77(1). 211–214. 31 indexed citations
2.
Swart, P. J., et al.. (1997). The in Vitro Anti-HIV Efficacy of Negatively Charged Human Serum Albumin Is Antagonized by Heparin. AIDS Research and Human Retroviruses. 13(8). 677–683. 4 indexed citations
3.
Chang, Kenneth S. S., et al.. (1993). Regulation of HIV-1 LTR trans-activating activities in two different human hepatocellular carcinoma cell lines. Cancer Letters. 74(1-2). 75–83. 6 indexed citations
4.
Chang, Kenneth S. S., et al.. (1991). Regulation of cellular trans-activating activities in two different promonocytic leukemia cell lines. Cancer Letters. 60(1). 75–83. 4 indexed citations
5.
Ablashi, Dharam V., N Balachandran, S.F. Josephs, et al.. (1991). Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology. 184(2). 545–552. 243 indexed citations
6.
Borellini, Flavia, Yugan He, A. Aquino, et al.. (1991). Increased DNA binding and transcriptional activity associated with transcription factor Sp1 in K562 cells transfected with the myeloid-specific c-fes tyrosine kinase gene. Journal of Biological Chemistry. 266(24). 15850–15854. 38 indexed citations
7.
Horvat, Rebecca T., Charles Wood, S.F. Josephs, & N Balachandran. (1991). Transactivation of the human immunodeficiency virus promoter by human herpesvirus 6 (HHV-6) strains GS and Z-29 in primary human T lymphocytes and identification of transactivating HHV-6(GS) gene fragments. Journal of Virology. 65(6). 2895–2902. 42 indexed citations
8.
Ablashi, D. V., S. Zaki Salahuddin, S.F. Josephs, et al.. (1991). Human herpesvirus-6 (HHV-6) (short review).. PubMed. 5(3). 193–9. 16 indexed citations
9.
Zagury, J.F., S.F. Josephs, G. Agius, et al.. (1990). In Vitro Characterization of a Biologically Active Molecular Clone of HIV-2 NIH-Z Containing a nef Deletion and Expressing a Full-Length Transmembrane Protein. AIDS Research and Human Retroviruses. 6(9). 1079–1085. 6 indexed citations
10.
Kalyanaraman, Vaniambadi S., et al.. (1990). Differential viral gene expression and its effect on the biological properties of the cell clones of an HIV-1-infected cell line. Virology. 177(1). 380–383. 5 indexed citations
11.
Borellini, Flavia, A. Aquino, S.F. Josephs, & Robert I. Glazer. (1990). Increased expression and DNA-binding activity of transcription factor Sp1 in doxorubicin-resistant HL-60 leukemia cells.. Molecular and Cellular Biology. 10(10). 5541–5547. 40 indexed citations
12.
Krueger, G. R. F., Birgit Koch, Albert Ramon, et al.. (1988). Antibody prevalence to HBLV (human herpesvirus-6, HHV-6) and suggestive pathogenicity in the general population and in patients with immune deficiency syndromes. Journal of Virological Methods. 21(1-4). 125–131. 39 indexed citations
13.
Harada, Hiroshi, M Takahashi, Akiko Tanaka, et al.. (1988). A repeat sequence, GGGTTA, is shared by DNA of human herpesvirus 6 and Marek's disease virus. Journal of Virology. 62(12). 4824–4827. 61 indexed citations
14.
Sadaie, M. Reza, Jay Rappaport, T. Benter, et al.. (1988). Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor.. Proceedings of the National Academy of Sciences. 85(23). 9224–9228. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026